Susan Horvath
2020
In 2020, Susan Horvath earned a total compensation of $414.2K as Chief Financial Officer and Vice President of Finance at Panbela Therapeutics, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $90,000 |
|---|---|
| Option Awards | $98,176 |
| Salary | $226,000 |
| Total | $414,176 |
Horvath received $226K in salary, accounting for 55% of the total pay in 2020.
Horvath also received $90K in non-equity incentive plan and $98.2K in option awards.
Rankings
In 2020, Susan Horvath's compensation ranked 11,495th out of 13,090 executives tracked by ExecPay. In other words, Horvath earned more than 12.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,495 out of 13,090 | 12th |
Division Manufacturing | 4,922 out of 5,621 | 12th |
Major group Chemicals And Allied Products | 2,029 out of 2,254 | 10th |
Industry group Drugs | 1,770 out of 1,954 | 9th |
Industry Pharmaceutical Preparations | 1,312 out of 1,459 | 10th |
Source: SEC filing on April 15, 2021.
Horvath's colleagues
We found two more compensation records of executives who worked with Susan Horvath at Panbela Therapeutics in 2020.